Innoviva
INVA · NASDAQ
$21.28+$0.20 (+0.95%)TodayMarket closed ·
Prev close $21.08
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 138.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.4447 | -$1.14 | −356.4% |
| Q1 FY26 | $0.3978 | -$0.05 | −112.6% |
| Q4 FY25 | $0.561 | $1.94 | +245.8% |
| Q3 FY25 | $0.4922 | $1.08 | +119.4% |
| Q2 FY25 | $0.51 | $0.77 | +51.0% |
| Q1 FY25 | $0.2958 | -$0.74 | −350.2% |
| Q4 FY24 | $0.3774 | $0.26 | −31.1% |
| Q3 FY24 | $0.2703 | $0.02 | −92.6% |
Earnings calls
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Citi's Biopharma Back to School Conference
- Goldman Sachs 46th Annual Global Healthcare Conference 2025
- Barclays 27th Annual Global Healthcare Conference 2025
- Citi's 2024 Global Healthcare Conference
- UBS Global Healthcare Conference 2024
- Goldman Sachs 45th Annual Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.